- Home
- AVIR vs PDLB Comparison
AVIR vs PDLB Comparison
Compare AVIR & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | PDLB |
|---|---|---|
| Founded | 2012 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 413.1M | 487.9M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AVIR | PDLB |
|---|---|---|
| Price | $4.17 | $21.27 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 277.8K | 72.7K |
| Earning Date | 11-11-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.00 | ★ 160.87 |
| EPS | N/A | ★ 0.71 |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.87 | $13.91 |
| 52 Week High | $6.45 | $21.10 |
Technical Indicators
Market Signals| Indicator | AVIR | PDLB |
|---|---|---|
| Relative Strength Index (RSI) | 30.76 | 69.53 |
| Support Level | $4.06 | $19.69 |
| Resistance Level | $4.46 | N/A |
| Average True Range (ATR) | 0.25 | 0.31 |
| MACD | -0.08 | 0.10 |
| Stochastic Oscillator | 17.69 | 94.93 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.